Arch Point Investors Nautilus Biotechnology, Inc. Transaction History

Arch Point Investors

  • $357 Million
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$0.67 - $0.93 $10,904 - $15,136
16,276 Added 2.69%
622,409 $448,000
Q4 2024

Feb 13, 2025
SELL
$1.67 - $2.96 $13,590 - $24,088
-8,138 Reduced 1.32%
606,133 $1.02 Million
Q2 2024

Aug 13, 2024
BUY
$2.22 - $3.0 $1.36 Million - $1.84 Million
614,271 New
614,271 $1.44 Million
Q4 2021

Feb 11, 2022
BUY
$4.45 - $6.21 $6.45 Million - $9 Million
1,449,551 New
1,449,551 $7.51 Million

Others Institutions Holding NAUT

# of Institutions
70
Shares Held
61.7M
Call Options Held
0
Put Options Held
0
View Full List

About Nautilus Biotechnology, Inc.

NAUT Quotes by TradingView
  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $227M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Arch Point Investors Portfolio

Follow Arch Point Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arch Point Investors, based on Form 13F filings with the SEC.

News

Stay updated on Arch Point Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email